In 2023, Japan's government expenditure on R&D in medical and health sciences was approximately 2.1 billion USD PPP (2015). The forecasted data from 2024 to 2028 shows a steady increase, reaching 2.51 billion USD PPP in 2028. The year-on-year percentage variation is approximately 4.76% from 2024 to 2025, 5% from 2025 to 2026, 4.33% from 2026 to 2027, and 4.15% from 2027 to 2028. The compound annual growth rate (CAGR) over the five-year period is about 4.57%.
Future trends to watch for:
- Potential policy shifts affecting budget allocations to health sciences.
- Impact of technological advancement on R&D efficiencies.
- The role of international collaboration in further boosting R&D activities.
